Home/Filings/4/0001209191-17-019464
4//SEC Filing

Kate Spade & Co 4

Accession 0001209191-17-019464

CIK 0000352363operating

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 8:20 PM ET

Size

28.1 KB

Accession

0001209191-17-019464

Insider Transaction Report

Form 4
Period: 2017-03-06
Yanussi Linda S
SVP IT and Global Operations
Transactions
  • Exercise/Conversion

    Common Stock, par value $1 per share

    2017-03-06+9,86810,833 total
  • Exercise/Conversion

    Common Stock, par value $1 per share

    2017-03-06+2,88210,331 total
  • Tax Payment

    Common Stock, par value $1 per share

    2017-03-06$23.37/sh990$23,1369,341 total
  • Exercise/Conversion

    Common Stock, par value $1 per share

    2017-03-06+1,80511,146 total
  • Tax Payment

    Common Stock, par value $1 per share

    2017-03-06$23.29/sh716$16,67610,430 total
  • Exercise/Conversion

    Common Stock, par value $1 per share

    2017-03-06+70911,139 total
  • Tax Payment

    Common Stock, par value $1 per share

    2017-03-06$23.29/sh244$5,68310,895 total
  • Exercise/Conversion

    Performance Market Share Units

    2017-03-062,8820 total
    From: 2017-03-06Common Stock, par value $1 per share (2,882 underlying)
  • Exercise/Conversion

    Market Share Units

    2017-03-067091,123 total
    From: 2017-03-06Common Stock, par value $1 per share (709 underlying)
  • Tax Payment

    Common Stock, par value $1 per share

    2017-03-06$23.29/sh3,384$78,8137,449 total
  • Exercise/Conversion

    Staking Market Share Units

    2017-03-069,86815,268 total
    From: 2017-03-06Common Stock, par value $1 per share (9,868 underlying)
  • Exercise/Conversion

    Market Share Units

    2017-03-061,8050 total
    From: 2017-03-06Common Stock, par value $1 per share (1,805 underlying)
Footnotes (11)
  • [F1]Staking market share units ("Staking MSUs") granted on March 3, 2014 and converted to shares of Issuer's common stock on a one-to-one basis upon vesting on March 6, 2017, in accordance with the terms of the 2014 Staking MSU award.
  • [F10]Represents 63.10% of target. The actual number of shares of common stock that vested was contingent on the market price of the Issuer's common stock during pre-determined intervals, with a potential payout ranging from 30% to 200% of the number of target MSUs awarded.
  • [F11]Each MSU represents the right to receive one share of common stock based on certain vesting conditions. The number of MSUs reported as beneficially owned following the reported transaction represents 50% of the target number awarded on March 2, 2015 corresponding to the second and final performance period ending on March 2, 2018.
  • [F2]Performance share units ("PSUs") granted on March 3, 2014 and converted to shares of Issuer's common stock on a one-to-one basis upon vesting on March 6, 2017, in accordance with the terms of the 2014 PSU award.
  • [F3]Market share units ("MSUs") granted on March 3, 2014 and converted to shares of Issuer's common stock on a one-to-one basis upon vesting on March 6, 2017, in accordance with the terms of the 2014 MSU award.
  • [F4]MSUs granted on March 2, 2015 and converted to shares of Issuer's common stock on a one-to-one basis upon vesting on March 6, 2017, in accordance with the terms of the 2015 MSU award.
  • [F5]Represents 64.63% of target. The actual number of shares of common stock that vested was contingent on the market price of the Issuer's common stock during pre-determined intervals, with a potential payout ranging from 30% to 200% of the number of target Staking MSUs awarded.
  • [F6]Not applicable.
  • [F7]Each Staking MSU represents the right to receive one share of common stock based on certain vesting conditions. The number of Staking MSUs reported as beneficially owned following the reported transaction represents 50% of the target number awarded on March 3, 2014 corresponding to the second and final performance period ending on March 3, 2019.
  • [F8]Represents 51.60% of target. The actual number of shares of common stock that vested was contingent on the Issuer's Cumulative Adjusted EBITDA and Average Cumulative Adjusted EBITDA Margin % achieved over the three year period from 2014 through 2017, adjusted to reflect the Issuer's total shareholder return ("TSR") performance relative to that of all companies in the S&P MidCap 400, with potential to earn a number of shares of common stock between 0% and 200% of the number of target PSUs awarded.
  • [F9]Represents 64.63% of target. The actual number of shares of common stock that vested was contingent on the market price of the Issuer's common stock during pre-determined intervals, with a potential payout ranging from 30% to 200% of the number of target MSUs awarded.

Issuer

Kate Spade & Co

CIK 0000352363

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000352363

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 8:20 PM ET
Size
28.1 KB